Major depressive disorder: New clinical, neurobiological, and treatment perspectives

The Lancet

Volumn 379, Issue 9820, 2012, Pages 1045-1055

  Kupfer, David J ^a   Frank, Ellen ^a   Phillips, Mary L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; DESVENLAFAXINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; ISOCARBOXAZID; KETAMINE; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PROTRIPTYLINE; S ADENOSYLMETHIONINE; SELEGILINE; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; VENLAFAXINE; VILAZODONE;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ANTIDEPRESSANT ACTIVITY; BOLD SIGNAL; BRAIN DEPTH STIMULATION; COGNITIVE THERAPY; COMORBIDITY; CORPUS STRIATUM; CYTOKINE PRODUCTION; DEPRESSIVE PSYCHOSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; FRACTIONAL ANISOTROPY; GENETIC VARIABILITY; HUMAN; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROBIOLOGY; NEUROTRANSMISSION; ORBITAL CORTEX; PREFRONTAL CORTEX; PREGNANCY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; REWARD; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL PHOBIA; SUICIDAL IDEATION; SUICIDE ATTEMPT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84858440408     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60602-8     Document Type: Review

References (153)

1. RC Kessler, P Berglund, O Demler for the National Comobordity Survey Replication The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA 289 2003 3095 3105
2. RC Kessler, M Angermeyer, JC Anthony et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative World Psychiatry 6 2007 168 176
3. S Moussavi, S Chatterji, E Verdes, A Tandon, V Patel, B Ustun Depression, chronic diseases, and decrements in health: results from the World Health Surveys Lancet 370 2007 851 858
4. P Tyrer Are general practitioners really unable to diagnose depression? Lancet 374 2009 589 590
5. AJ Mitchell, A Vaze, S Rao Clinical diagnosis of depression in primary care: a meta-analysis Lancet 374 2009 609 619
6. J Das-Munshi, D Goldberg, PE Bebbington et al. Public health significance of mixed anxiety and depression: beyond current classification Br J Psychiatry 192 2008 171 177
7. F Benazzi Bipolar disorder - focus on bipolar II disorder and mixed depression Lancet 369 2007 935 945
8. HS Akiskal, O Pinto The soft bipolar spectrum: footnotes to Kraepelin on the interface of hypomania, temperament and depression A Marneros J Angst Bipolar disorders: 100 years after manic-depressive insanity 2000 Kluwer Academic Dorderecht, Netherlands 37 62
9. GB Cassano, P Rucci, E Frank et al. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach Am J Psychiatry 161 2004 1264 1269
10. CD Schneck Mixed depression: the importance of rediscovering subtypes of mixed mood states Am J Psychiatry 166 2009 127 130
11. TE Moffitt, H Harrington, A Caspi et al. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years Arch Gen Psychiatry 64 2007 651 660
12. K Beesdo, A Bittner, DS Pine et al. Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life Arch Gen Psychiatry 64 2007 903 912
13. R Michels Personality disorders in the depressed: seeing clearly through blue lenses Am J Psychiatry 167 2010 487 488
14. FS Luppino, LM de Wit, PF Bouvy et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies Arch Gen Psychiatry 67 2010 220 229
15. KS Kendler, CO Gardner, A Fiske, M Gatz Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources of comorbidity Arch Gen Psychiatry 66 2009 857 863
16. AH Glassman, JT Bigger Jr, M Gaffney Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants Arch Gen Psychiatry 66 2009 1022 1029
17. N Frasure-Smith, F Lespérance Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease Arch Gen Psychiatry 65 2009 62 71
18. BD Thombs, P de Jonge, JC Coyne et al. Depression screening and patient outcomes in cardiovascular care: a systematic review JAMA 300 2008 2161 2171
19. M Mitka Routine depression screening advised for patients with coronary heart disease JAMA 300 2008 2356 2357
20. A Campayo, P de Jonge, JF Roy, P Saz for the ZARADEMP Project Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression Am J Psychiatry 167 2010 580 588
21. CG Lyketsos Depression and diabetes: more on what the relationship might be Am J Psychiatry 167 2010 496 497
22. D Goldberg The detection and treatment of depression in the physically ill World Psychiatry 9 2010 16 20
23. R Uher The role of genetic variation in the causation of mental illness: an evolution-informed framework Mol Psychiatry 14 2009 1072 1082
24. SI Shyn, SP Hamilton The genetics of major depression: moving beyond the monoamine hypothesis Psychiatr Clin North Am 33 2010 125 140
25. EF van Rossum, EB Binder, M Majer et al. Polymorphisms of the glucocorticoid receptor gene and major depression Biol Psychiatry 59 2006 681 688
26. M Fan, B Liu, T Jiang, X Jiang, H Zhao, J Zhang Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders Psychiatr Genet 20 2010 1 7
27. HK Yoon, YK Kim Association between glycogen synthase kinase-3β gene polymorphisms and major depression and suicidal behavior in a Korean population Prog NeuroPscyhopharmacol Biol Psychiatry 34 2010 331 334
28. T Tsunoka, T Kishi, M Ikeda et al. Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population Prog NeuroPsychopharmacol Biol Psychiatry 33 2009 875 879
29. A Serretti, M Kato, D De Ronchi, T Kinoshita Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients Mol Psychiatry 12 2007 247 257
30. P Huezo-Diaz, R Uher, R Smith et al. Moderation of antidepressant response by the serotonin transporter gene Br J Psychiatry 195 2009 30 38
31. M Kato, A Serretti Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder Mol Psychiatry 15 2010 473 500
32. GM Murphy Jr, SB Hollander, HE Rodrigues, C Kremer, AF Schatzberg Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression Arch Gen Psychiatry 61 2004 1163 1169
33. S Horstmann, S Lucae, A Menke et al. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment Neuropsychopharmacology 35 2010 727 740
34. MJ Wilkie, G Smith, RK Day et al. Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy Pharmacogenomics J 9 2009 61 70
35. FJ McMahon, S Buervenich, D Charney et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment Am J Hum Genet 78 2006 804 814
36. RH Perlis, G Laje, JW Smoller, M Fava, AJ Rush, FJ McMahon Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients Neuropsychopharmacology 34 2009 1819 1828
37. S Paddock, G Laje, D Charney et al. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort Am J Psychiatry 164 2007 1181 1188
38. G Laje, S Paddock, H Manji et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression Am J Psychiatry 164 2007 1530 1538
39. J Licinio, C Dong, ML Wong Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response Arch Gen Psychiatry 66 2009 488 497
40. EB Binder The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders Psychoneuroendocrinology 34 suppl 2009 S186 S195
41. EB Binder, D Salyakina, P Lichtner et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment Nat Genet 36 2004 1319 1325
42. M Lekman, G Laje, D Charney et al. The FKBP5-gene in depression and treatment response - an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort Biol Psychiatry 63 2008 1103 1110
43. RH Perlis, P Moorjani, J Fagerness et al. Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study Neuropsychopharmacology 33 2008 2810 2819
44. BT Baune, C Hohoff, K Berger et al. Association of the COMT val158met variant with antidepressant treatment response in major depression Neuropsychopharmacology 33 2008 924 932
45. RH Perlis, B Fijal, DH Adams et al. Variation in catechol-O- methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder Biol Psychiatry 65 2009 785 791
46. EB Binder, MJ Owens, W Liu et al. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response Arch Gen Psychiatry 67 2010 369 379
47. Z Liu, F Zhu, G Wang et al. Association study of corticotropin-releasing hormone receptor 1 gene polymorphisms and antidepressant response in major depressive disorders Neuroscience Lett 414 2007 155 158
48. R Uher, N Perroud, MY Ng et al. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project Am J Psychiatry 167 2010 555 564
49. S Sen, R Duman, G Sanacora Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications Biol Psychiatry 64 2008 527 532
50. AR Brunoni, M Lopes, F Fregni A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression Int J Neuropsychopharmacol 11 2008 1169 1180
51. CL Raison, AS Borisov, M Majer et al. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression Biol Psychiatry 65 2009 296 303
52. R Dantzer, JC O'Connor, GG Freund, RW Johnson, KW Kelley From inflammation to sickness and depression: when the immune system subjugates the brain Nat Rev Neurosci 9 2008 46 56
53. D Brustolim, R Ribeiro-dos-Santos, RE Kast, EL Altschuler, MB Soares A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice Int Immunopharmacol 6 2006 903 907
54. F Holsboer The corticosteroid receptor hypothesis of depression Neuropsychopharmacology 23 2000 477 501
55. M Ising, S Horstmann, S Kloiber et al. Combined dexamethasone/ corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker? Biol Psychiatry 62 2007 47 54
56. ML Phillips, CD Ladouceur, WC Drevets A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder Mol Psychiatry 13 2008 833 857
57. A Bertolino, G Arciero, V Rubino et al. Variation of human amygdala response during threatening stimuli as a function of 5′HTTLPR genotype and personality style Biol Psychiatry 57 2005 1517 1525
58. AR Hariri, EM Drabant, KE Munoz et al. A susceptibility gene for affective disorders and the response of the human amygdala Arch Gen Psychiatry 62 2005 146 152
59. A Heinz, MN Smolka, DF Braus et al. Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation Biol Psychiatry 61 2007 1011 1014
60. W Schultz Behavioral dopamine signals Trends Neurosci 30 2007 203 210
61. S Surguladze, MJ Brammer, P Keedwell et al. A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder Biol Psychiatry 57 2005 201 209
62. PA Keedwell, C Andrew, SC Williams, MJ Brammer, ML Phillips A double dissociation of ventromedial prefrontal cortical responses to sad and happy stimuli in depressed and healthy individuals Biol Psychiatry 58 2005 495 503
63. U Dannlowski, P Ohrmann, J Bauer et al. Amygdala reactivity to masked negative faces is associated with automatic judgmental bias in major depression: a 3 T fMRI study J Psychiatry Neurosci 32 2007 423 429
64. CH Fu, J Mourao-Miranda, SG Costafreda et al. Pattern classification of sad facial processing: toward the development of neurobiological markers in depression Biol Psychiatry 63 2008 656 662
65. CL Fales, DM Barch, MM Rundle et al. Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression Biol Psychiatry 63 2008 377 384
66. J Epstein, H Pan, JH Kocsis et al. Lack of ventral striatal response to positive stimuli in depressed versus normal subjects Am J Psychiatry 163 2006 1784 1790
67. DA Pizzagalli, AJ Holmes, DG Dillon et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder Am J Psychiatry 166 2009 702 710
68. EE Forbes, AR Hariri, SL Martin et al. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder Am J Psychiatry 166 2009 64 73
69. G Kronenberg, L Tebartz van Elst, F Regen, M Deuschle, I Heuser, M Colla Reduced amygdala volume in newly admitted psychiatric in-patients with unipolar major depression J Psychiatr Res 43 2009 1112 1117
70. VM Dotson, C Davatzikos, MA Kraut, SM Resnick Depressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study J Psychiatry Neurosci 34 2009 367 375
71. G Rajkowska, G O'Dwyer, Z Teleki, CA Stockmeier, JJ Miguel-Hidalgo GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression Neuropsychopharmacology 32 2007 471 482
72. JR Almeida, A Versace, A Mechelli et al. Abnormal amygdala-prefrontal effective connectivity to happy faces differentiates bipolar from major depression Biol Psychiatry 66 2009 451 459
73. L Li, N Ma, Z Li et al. Prefrontal white matter abnormalities in young adult with major depressive disorder: a diffusion tensor imaging study Brain Res 1168 2007 124 128
74. DA Gusnard, E Akbudak, GL Shulman, ME Raichle Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function Proc Natl Acad Sci USA 98 2001 4259 4264
75. MD Greicius, BH Flores, V Menon et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus Biol Psychiatry 62 2007 429 437
76. PB Fitzgerald, AR Laird, J Maller, ZJ Daskalakis A meta-analytic study of changes in brain activation in depression Hum Brain Mapp 29 2008 683 695
77. DA Pizzagalli Frontocingulate dysfunction in depression: toward biomarkers of treatment response Neuropsychopharmacology 36 2011 183 206
78. A Anand, Y Li, Y Wang et al. Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study Neuropsychopharmacology 30 2005 1334 1344
79. A Anand, Y Li, Y Wang, K Gardner, MJ Lowe Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study J Neuropsychiatry Clin Neurosci 19 2007 274 282
80. G Salvadore, BR Cornwell, F Sambataro et al. Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine Neuropsychopharmacology 35 2010 1415 1422
81. GJ Siegle, CS Carter, ME Thase Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy Am J Psychiatry 163 2006 735 738
82. HS Mayberg, AM Lozano, V Voon et al. Deep brain stimulation for treatment-resistant depression Neuron 45 2005 651 660
83. TE Schlaepfer, MX Cohen, C Frick et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression Neuropsychopharmacology 33 2008 368 377
84. HP Blumberg, F Wang, LG Chepenik et al. Influence of vascular endothelial growth factor variation on human hippocampus morphology Biol Psychiatry 64 2008 901 903
85. KI Erickson, RS Prakash, MW Voss et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume J Neurosci 30 2010 5368 5375
86. F Soliman, CE Glatt, KG Bath et al. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human Science 327 2010 863 866
87. L Pezawas, A Meyer-Lindenberg, AL Goldman et al. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression Mol Psychiatry 13 2008 709 716
88. RT Joffe, JM Gatt, AH Kemp et al. Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: implications for depressive illness Hum Brain Mapp 30 2009 1246 1256
89. A Zobel, F Jessen, O von Widdern et al. Unipolar depression and hippocampal volume: impact of DNA sequence variants of the glucocorticoid receptor gene Am J Med Genet B Neuropsychiatr Genet 147B 2008 836 843
90. NA Harrison, L Brydon, C Walker, MA Gray, A Steptoe, HD Critchley Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity Biol Psychiatry 66 2009 407 414
91. BT Baune, U Dannlowski, K Domschke et al. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression Biol Psychiatry 67 2010 543 549
92. C Gaiteri, JP Guilloux, DA Lewis, E Sibille Altered gene synchrony suggests a combined hormone-mediated dysregulated state in major depression PLoS One 5 2010 e9970
93. DG Dillon, R Bogdan, J Fagerness, AJ Holmes, RH Perlis, DA Pizzagalli Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans Hum Brain Mapp 31 2010 210 221
94. A Versace, JR Almeida, K Quevedo et al. Right orbitofrontal corticolimbic and left corticocortical white matter connectivity differentiate bipolar and unipolar depression Biol Psychiatry 68 2010 560 567
95. JR Almeida, A Versace, S Hassel, DJ Kupfer, ML Phillips Elevated amygdala activity to sad facial expressions: a state marker of bipolar but not unipolar depression Biol Psychiatry 67 2010 414 421
96. RC Craddock, PE Holtzheimer 3rd, XP Hu, HS Mayberg Disease state prediction from resting state functional connectivity Magn Reson Med 62 2009 1619 1628
97. P Cuijpers, J Dekker, SD Hollon, G Andersson Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis J Clin Psychiatry 70 2009 1219 1229
98. P Cuijpers, A van Straten, P van Oppen, G Andersson Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies J Clin Psychiatry 69 2008 1675 1685
99. B Bortolotti, M Menchetti, F Bellini, MB Montaguti, D Berardi Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials Gen Hosp Psychiatry 30 2008 293 302
100. NJ Wolf, DR Hopko Psychosocial and pharmacological interventions for depressed adults in primary care: a critical review Clin Psychol Rev 28 2008 131 161
101. E Schramm, D van Calker, P Dykierek et al. An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results Am J Psychiatry 164 2007 768 777
102. E Frank, DJ Kupfer, DJ Buysse et al. Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression Am J Psychiatry 164 2007 761 767
103. JR Vittengl, LA Clark, RB Jarrett Continuation-phase cognitive therapy's effects on remission and recovery from depression J Consult Clin Psychol 77 2009 367 371
104. SD Hollon, RJ DeRubeis, RC Shelton et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression Arch Gen Psychiatry 62 2005 417 422
105. GE Simon, EJ Ludman, CM Rutter Incremental benefit and cost of telephone care management and telephone psychotherapy for depression in primary care Arch Gen Psychiatry 66 2009 1081 1089
106. D Kessler, G Lewis, S Kaur et al. Therapist-delivered Internet psychotherapy for depression in primary care: a randomised controlled trial Lancet 374 2009 628 634
107. SE Luty, JD Carter, JM McKenzie et al. Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression Br J Psychiatry 190 2007 496 502
108. AC Bell, TJ D'Zurilla Problem-solving therapy for depression: a meta-analysis Clin Psychol Rev 29 2009 348 353
109. B Schreuders, H van Marwijk, J Smit, F Rijmen, W Stalman, P van Oppen Primary care patients with mental health problems: outcome of a randomised clinical trial Br J Gen Pract 57 2009 886 891
110. M Olfson, SC Marcus National patterns in antidepressant medication treatment Arch Gen Psychiatry 66 2009 848 856
111. American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder, 3rd edn http://www.psychiatryonline. com/pracGuide/pracGuideTopic-7.aspx November, 2010 (accessed Feb 16, 2011).
112. KP Ebmeier, C Donaghey, JD Steele Recent developments and current controversies in depression Lancet 367 2006 153 167
113. AJ Rush, M Fava, SR Wisniewski for the STAR*D Investigators Group Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design Control Clin Trials 25 2004 119 142
114. AJ Rush, MH Trivedi, SR Wisniewski et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report Am J Psychiatry 163 2006 1905 1917
115. ME Thase, ES Friedman, MM Biggs et al. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report Am J Psychiatry 164 2007 739 752
116. BN Gaynes, D Warden, MH Trivedi, SR Wisniewski, M Fava, AJ Rush What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression Psychiatr Serv 60 2009 1439 1445
117. T Bschor, C Baethge No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy Acta Psychiatr Scand 121 2010 174 179
118. AJ Rush Combining antidepressant medications: a good idea? Am J Psychiatry 167 2010 241 243
119. KR Connolly, ME Thase If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies Drugs 71 2011 43 64
120. M Bauer, M Adli, T Bschor et al. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants Neuropsychobiology 62 2010 36 42
121. GI Papakostas, RC Shelton, J Smith, M Fava Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis J Clin Psychiatry 68 2007 826 831
122. Tomba E, Fava GA. The sequential combination of pharmacotherapy and psychotherapy in mood disorders. J Contemp Psycho 39: 101-09.
123. BS Meyers, AJ Flint, AJ Rothschild for the STOP-PD Group A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD) Arch Gen Psychiatry 66 2009 838 847
124. J Wijkstra, H Burger, WW van den Broek et al. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine Acta Psychiatr Scand 121 2010 190 200
125. JC Nelson S-adenosyl methionine (SAMe) augmentation in major depressive disorder Am J Psychiatry 167 2010 889 891
126. GI Papakostas, D Mischoulon, I Shyu, JE Alpert, M Fava S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial Am J Psychiatry 167 2010 942 948
127. JH Krystal N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants Arch Gen Psychiatry 67 2010 1110 1111
128. CA Zarate Jr, JB Singh, PJ Carlson et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 2006 856 864
129. M aan het Rot, KA Collins, JW Murrough et al. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression Biol Psychiatry 67 2010 139 145
130. A Ghosh, JS Hellewell A review of the efficacy and tolerability of agomelatine in the treatment of major depression Expert Opin Investig Drugs 16 2007 1999 2004
131. JP Olié, S Kasper Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder Int J Neuropsychopharmacol 10 2007 661 673
132. SM Stahl, M Fava, MH Trivedi, A Caputo, A Shah, A Post Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial J Clin Psychiatry 71 2010 616 626
133. GM Goodwin, R Emsley, S Rembry, F Rouillon for the Agomelatine Study Group Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial J Clin Psychiatry 70 2009 1128 1137
134. Olfson M, Marcus SC. A case-control study of antidepressants and attempted suicide during early phase treatment of major depressive episodes. J Clin Psychiatry 69: 425-32.
135. M Olfson, SC Marcus, D Shaffer Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study Arch Gen Psychiatry 63 2006 865 872
136. RD Gibbons, CH Brown, K Hur, SM Marcus, DK Bhaumik, JJ Mann Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets Am J Psychiatry 164 2007 1044 1049
137. RD Gibbons, K Hur, DK Bhaumik, JJ Mann The relationship between antidepressant medication use and rate of suicide Arch Gen Psychiatry 62 2005 165 172
138. M Tuccori, A Testi, L Antonioli et al. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review Clin Ther 31 2009 1426 1453
139. EL Moses-Kolko, D Bogen, J Perel et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications JAMA 293 2005 2372 2383
140. KL Wisner, DK Sit, BH Hanusa et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes Am J Psychiatry 166 2009 557 566
141. US Food and Drug Administration Public health advisory: paroxetine http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051731. htm (accessed Dec 8, 2010).
142. Medicines and Healthcare Products Regulatory Agency MHRA update on the risks of birth defects in babies born to mothers taking paroxetine - q&a http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con2022700. pdf (accessed Dec 8, 2010).
143. HE Ward, N Hwynn, MS Okun Update on deep brain stimulation for neuropsychiatric disorders Neurobiol Dis 38 2010 346 353
144. J Kuhn, TO Gründler, D Lenartz, V Sturm, J Klosterkötter, W Huff Deep brain stimulation for psychiatric disorders Dtsch Arztebl Int 107 2010 105 113
145. P Giacobbe, SH Kennedy Deep brain stimulation for treatment-resistant depression: a psychiatric perspective Curr Psychiatry Rep 8 2006 437 444
146. BH Kopell, B Greenberg, AR Rezai Deep brain stimulation for psychiatric disorders J Clin Neurophysiol 21 2004 51 67
147. BH Bewernick, R Hurlemann, A Matusch et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression Biol Psychiatry 67 2010 110 116
148. AM Lozano, HS Mayberg, P Giacobbe, C Hamani, RC Craddock, SH Kennedy Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression Biol Psychiatry 64 2008 461 467
149. DA Malone Jr, DD Dougherty, AR Rezai et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression Biol Psychiatry 65 2009 267 275
150. DR Kim, A Pesiridou, JP O'Reardon Transcranial magnetic stimulation in the treatment of psychiatric disorders Curr Psychiatry Rep 11 2009 447 452
151. B Dell'osso, AC Altamura Augmentative transcranial magnetic stimulation (TMS) combined with brain navigation in drug-resistant rapid cycling bipolar depression: a case report of acute and maintenance efficacy World J Biol Psychiatry 10 2009 673 676
152. CW Slotema, JD Blom, HW Hoek, IE Sommer Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders J Clin Psychiatry 71 2010 873 884
153. SH Lisanby, MM Husain, PB Rosenquist et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial Neuropsychopharmacology 34 2009 522 534